These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 21842244)

  • 21. Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy.
    Lee KH; Im SA; Oh DY; Lee SH; Chie EK; Han W; Kim DW; Kim TY; Park IA; Noh DY; Heo DS; Ha SW; Bang YJ
    BMC Cancer; 2007 Apr; 7():63. PubMed ID: 17430582
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use and outcomes of adjuvant chemotherapy in older women with breast cancer.
    Giordano SH; Duan Z; Kuo YF; Hortobagyi GN; Goodwin JS
    J Clin Oncol; 2006 Jun; 24(18):2750-6. PubMed ID: 16782915
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Racial disparities in initiation of adjuvant endocrine therapy of early breast cancer.
    Reeder-Hayes KE; Meyer AM; Dusetzina SB; Liu H; Wheeler SB
    Breast Cancer Res Treat; 2014 Jun; 145(3):743-51. PubMed ID: 24789443
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neratinib after trastuzumab-based adjuvant therapy in patients with HER2-positive breast cancer (ExteNET): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
    Chan A; Delaloge S; Holmes FA; Moy B; Iwata H; Harvey VJ; Robert NJ; Silovski T; Gokmen E; von Minckwitz G; Ejlertsen B; Chia SKL; Mansi J; Barrios CH; Gnant M; Buyse M; Gore I; Smith J; Harker G; Masuda N; Petrakova K; Zotano AG; Iannotti N; Rodriguez G; Tassone P; Wong A; Bryce R; Ye Y; Yao B; Martin M;
    Lancet Oncol; 2016 Mar; 17(3):367-377. PubMed ID: 26874901
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Concurrent vs sequential adjuvant chemotherapy and hormone therapy in breast cancer: a multicenter randomized phase III trial.
    Bedognetti D; Sertoli MR; Pronzato P; Del Mastro L; Venturini M; Taveggia P; Zanardi E; Siffredi G; Pastorino S; Queirolo P; Gardin G; Wang E; Monzeglio C; Boccardo F; Bruzzi P
    J Natl Cancer Inst; 2011 Oct; 103(20):1529-39. PubMed ID: 21921285
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Radiation therapy use and outcomes among older women with ER-positive and ER-negative stage I breast cancer.
    Shen X; Anne PR; Keith SW; Wojcieszynski A; Mishra MV; Bar-Ad V; Showalter TN
    Am J Clin Oncol; 2014 Jun; 37(3):241-7. PubMed ID: 23241502
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Initiation of Trastuzumab by Women Younger Than 64 Years for Adjuvant Treatment of Stage I-III Breast Cancer.
    Tsai HT; Isaacs C; Lynce FC; O'Neill SC; Liu C; Schwartz MD; Selvam N; Zhou Y; Potosky AL
    J Natl Compr Canc Netw; 2017 May; 15(5):601-607. PubMed ID: 28476740
    [No Abstract]   [Full Text] [Related]  

  • 28. Racial Differences in Adjuvant Endocrine Therapy Use and Discontinuation in Association with Mortality among Medicare Breast Cancer Patients by Receptor Status.
    Farias AJ; Du XL
    Cancer Epidemiol Biomarkers Prev; 2017 Aug; 26(8):1266-1275. PubMed ID: 28515111
    [No Abstract]   [Full Text] [Related]  

  • 29. Practice patterns and outcomes for patients with node-negative hormone receptor-positive breast cancer and intermediate 21-gene Recurrence Scores.
    Chen J; Wu X; Christos PJ; Formenti S; Nagar H
    Breast Cancer Res; 2018 Apr; 20(1):26. PubMed ID: 29661221
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Timing of adjuvant chemotherapy initiation after surgery for stage III colon cancer.
    Hershman D; Hall MJ; Wang X; Jacobson JS; McBride R; Grann VR; Neugut AI
    Cancer; 2006 Dec; 107(11):2581-8. PubMed ID: 17078055
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adjuvant chemotherapy and survival among patients 70 years of age and younger with node-negative breast cancer and the 21-gene recurrence score of 26-30.
    Park S; Han Y; Liu Y; Toriola AT; Peterson LL; Colditz GA; Kim SI; Cho YU; Park BW; Park Y
    Breast Cancer Res; 2019 Oct; 21(1):110. PubMed ID: 31619259
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Evolving Complexity of Treating Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor-2 (HER2)-Negative Breast Cancer: Special Considerations in Older Breast Cancer Patients-Part I: Early-Stage Disease.
    Sammons S; Sedrak MS; Kimmick GG
    Drugs Aging; 2020 May; 37(5):331-348. PubMed ID: 32100240
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical and economic outcomes associated with adjuvant chemotherapy in elderly patients with early stage operable breast cancer.
    Sail KR; Franzini L; Lairson DR; Du XL
    Value Health; 2012 Jan; 15(1):72-80. PubMed ID: 22264974
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chemotherapy use and surgical treatment by receptor subtype in node-negative T1a and T1b female breast cancers, Iowa SEER Registry, 2010 to 2012.
    Schroeder MC; Lynch CF; Abu-Hejleh T; Chrischilles EA; Thomas A
    Clin Breast Cancer; 2015 Feb; 15(1):e27-34. PubMed ID: 25245424
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluating the association between adjuvant chemotherapy and function-related adverse events among older patients with early stage breast cancer.
    Mariano C; Lund JL; Peacock Hinton S; Htoo P; Muss H; Reeder-Hayes KE
    J Geriatr Oncol; 2017 Jul; 8(4):242-248. PubMed ID: 28601373
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adjuvant denosumab in early breast cancer (D-CARE): an international, multicentre, randomised, controlled, phase 3 trial.
    Coleman R; Finkelstein DM; Barrios C; Martin M; Iwata H; Hegg R; Glaspy J; Periañez AM; Tonkin K; Deleu I; Sohn J; Crown J; Delaloge S; Dai T; Zhou Y; Jandial D; Chan A
    Lancet Oncol; 2020 Jan; 21(1):60-72. PubMed ID: 31806543
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Community-based use of chemotherapy and hormonal therapy for early-stage breast cancer: 1987-2000.
    Harlan LC; Clegg LX; Abrams J; Stevens JL; Ballard-Barbash R
    J Clin Oncol; 2006 Feb; 24(6):872-7. PubMed ID: 16484696
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Variation in guideline-concordant care for elderly patients with metastatic breast cancer in the United States.
    Poorvu PD; Vaz-Luis I; Freedman RA; Lin NU; Barry WT; Winer EP; Hassett MJ
    Breast Cancer Res Treat; 2018 Apr; 168(3):727-737. PubMed ID: 29332137
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Delayed Initiation of Adjuvant Chemotherapy Among Patients With Breast Cancer.
    Chavez-MacGregor M; Clarke CA; Lichtensztajn DY; Giordano SH
    JAMA Oncol; 2016 Mar; 2(3):322-9. PubMed ID: 26659132
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predicting Late-stage Breast Cancer Diagnosis and Receipt of Adjuvant Therapy: Applying Current Spatial Access to Care Methods in Appalachia.
    Donohoe J; Marshall V; Tan X; Camacho FT; Anderson R; Balkrishnan R
    Med Care; 2015 Nov; 53(11):980-8. PubMed ID: 26465126
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.